Related references
Note: Only part of the references are listed.Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies
Jordan S. Orange et al.
CLINICAL IMMUNOLOGY (2010)
Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency
John B. Hagan et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Strategies to Extend Plasma Half-Lives of Recombinant Antibodies
Roland E. Kontermann
BIODRUGS (2009)
Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency
Richard L. Wasserman et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
A pilot study of equal doses of 10% IGIV given intravenously or subcutaneously
Shilpa H. Desai et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Stability over 36 months of a new liquid 10% polyclonal immunoglobulin product (IgPro10, Privigen<(C)>) stabilized with L-proline
M. Cramer et al.
VOX SANGUINIS (2009)
Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies
R. Gustafson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Subcutaneous Administration of IgG
Melvin Berger
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)
Immunoglobulin treatment for primary antibody deficiencies - Advantages of the subcutaneous route
Ann Gardulf
BIODRUGS (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children
Wasu Kamchaisatian et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases
Hans D. Ochs et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies -: A prospective, multi-national study
Ann Gardulf et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubelia vaccination in children treated for acute lymphoblastic leukemia
TE Ercan et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2005)
The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia - A randomized, double-blind, multicenter crossover trial
HW Eijkhout et al.
ANNALS OF INTERNAL MEDICINE (2001)
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
HM Chapel et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2000)
Share Paper
